These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30475863)

  • 1. PPE17 (Rv1168c) protein of Mycobacterium tuberculosis detects individuals with latent TB infection.
    Abraham PR; Devalraju KP; Jha V; Valluri VL; Mukhopadhyay S
    PLoS One; 2018; 13(11):e0207787. PubMed ID: 30475863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal domain of Mycobacterium tuberculosis PPE17 (Rv1168c) protein plays a dominant role in inducing antibody responses in active TB patients.
    Abraham PR; Pathak N; Pradhan G; Sumanlatha G; Mukhopadhyay S
    PLoS One; 2017; 12(6):e0179965. PubMed ID: 28651002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
    PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis.
    Petruccioli E; Vanini V; Chiacchio T; Cuzzi G; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2017 Sep; 106():38-43. PubMed ID: 28802403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of QuantiFERON®-TB Gold in-tube culture supernatants for measurement of antibody responses.
    Kimuda SG; Andia-Biraro I; Egesa M; Bagaya BS; Raynes JG; Levin J; Elliott AM; Cose S
    PLoS One; 2017; 12(11):e0188396. PubMed ID: 29161328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.
    Xiao JN; Xiong Y; Chen Y; Xiao YJ; Ji P; Li Y; Wang SJ; Zhao GP; Cheng QJ; Lu SH; Wang Y
    Front Cell Infect Microbiol; 2017; 7():495. PubMed ID: 29250493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong purified protein derivative responses are associated with poor mycobacterium inhibition in latent TB.
    Kang JS; Cherian A; Gan SH; Lee TH; Lee KC; Chee CB; Doherty TM; Wang YT; Seah GT
    Eur Respir J; 2010 Aug; 36(2):348-54. PubMed ID: 19996195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities.
    Chien JY; Chiang HT; Lu MC; Ko WC; Yu CJ; Chen YH; Hsueh PR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29793966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the CD4 and CD8 T-cell response in the QuantiFERON-TB Gold Plus kit.
    Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Palmieri F; Cirillo DM; Ippolito G; Goletti D
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S25-S26. PubMed ID: 28043588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential novel markers to discriminate between active and latent tuberculosis infection in Chinese individuals.
    Bai XJ; Liang Y; Yang YR; Feng JD; Luo ZP; Zhang JX; Wu XQ
    Comp Immunol Microbiol Infect Dis; 2016 Feb; 44():8-13. PubMed ID: 26851588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
    Della Bella C; Spinicci M; Grassi A; Bartalesi F; Benagiano M; Truthmann K; Tapinassi S; Troilo A; D'Elios S; Alnwaisri H; Shuralev E; Singh M; Bartoloni A; D'Elios MM
    PLoS One; 2018; 13(6):e0197825. PubMed ID: 29856871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.
    Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Cirillo DM; Palmieri F; Ippolito G; Goletti D
    J Infect; 2016 Dec; 73(6):588-597. PubMed ID: 27717779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological characterization of latent tuberculosis infection in a low endemic country.
    de Paus RA; van Meijgaarden KE; Prins C; Kamphorst MH; Arend SM; Ottenhoff THM; Joosten SA
    Tuberculosis (Edinb); 2017 Sep; 106():62-72. PubMed ID: 28802407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
    Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
    Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.